G2 Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Buy
2,745
+16
+0.6% +$3.73K 0.16% 40
2025
Q4
$565K Buy
2,729
+33
+1% +$6.53K 0.14% 40
2025
Q3
$500K Buy
2,696
+126
+5% +$21.6K 0.13% 40
2025
Q2
$393K Hold
2,570
0.11% 45
2025
Q1
$426K Hold
2,570
0.13% 44
2024
Q4
$372K Hold
2,570
0.11% 46
2024
Q3
$416K Hold
2,570
0.12% 45
2024
Q2
$376K Hold
2,570
0.12% 46
2024
Q1
$407K Hold
2,570
0.13% 46
2023
Q4
$403K Buy
+2,570
New +$394K 0.14% 45

Other funds holding JNJ

G2 Capital Management's JNJ Position: Q1 2026 in Review

G2 Capital Management increased its Johnson & Johnson (JNJ) stake by 0.59% in Q1 2026, buying an estimated $3.73K and bringing the position to 2,745 shares worth $671K. The position accounts for 0.16% of the portfolio, ranked #40.

G2 Capital Management first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • G2 Capital Management held 2,745 shares of Johnson & Johnson worth $671K as of Q1 2026.
  • G2 Capital Management bought 16 Johnson & Johnson shares in Q1 2026, an estimated $3.73K.
  • Johnson & Johnson made up 0.16% of G2 Capital Management's portfolio in Q1 2026, its #40 holding.
  • G2 Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on G2 Capital Management's 13F filing for Q1 2026, filed 12 May 2026.